Pharmacokinetics and hypotensive effect of diltiazem in rabbits: Comparison of diltiazem with its major metabolites

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 11, 1998, Pages 1247-1253

  Yeung, Pollen K F ^a   Feng, Joe D Z ^a   Buckley, Susan J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DEACETYL N NORDILTIAZEM; DEACETYLDILTIAZEM; DILTIAZEM; DRUG METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HEART RATE; HEMODYNAMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RABBIT; SYSTOLIC BLOOD PRESSURE;

EID: 0031790624     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb03341.x     Document Type: Article

References (27)

1. Caille, G., Dube, L. M., Theoret, Y., Varin, F., Mousseau, N. I. J. M. (1989) Stability study of diltiazem and two of its metabolites using a high-performance liquid chromatographic method. Biopharm. Drug Dispos. 10: 107-114
2. Eliot, L., Mayo, P., Jamali, F. (1997) Inflammatory disease in HLA-B27 (HB) and human B2M (H2) expressed transgenic rats reduces nifedipine induced tachycardia. Pharm. Res. 14 (Suppl.): S511
3. Epstein, M. (1997) The calcium antagonist controversy: the emerging importance of drug formulation as a determinant of risk. Am. J. Cardiol. 79: 9-19
4. Fleishaker, J. C., Phillips, J. P., Smith, T. C., Smith, R. B. (1989) Multiple-dose pharmacokinetics and pharmacodynamics of adinazolam in elderly subjects. Pharm. Res. 6: 379-386
5. Gabrielsson, J., Weiner, D. (1994) Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. 1st Swedish Pharmaceutical Press, Stockholm, Sweden
6. Gibaldi, M., Perrier, D. (1982) Pharmacokinetics. 2nd edn, Marcel Dekker, New York
7. Halbrugge, T., Friedgen, B., Ludwig, J., Graefe, K.-H. (1993) Effects of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3,4-dihydroxyphenylglycol in the rabbit. Naunyn-Schmiedebergs Arch Pharmacol. 347: 162-170
8. Holford, N., Sheiner, L. (1981) Pharmacokinetic and pharmacodynamic modeling in vivo. CRC Crit. Rev. Bioeng. July: 273-321
9. Kiyomoto, A., Sasaki, Y., Odawara, A., Morita, T. (1983) Inhibition of platelet aggregation by diltiazem. Circ. Res. 52 (Suppl. I): 115-119
10. Li, R., Farmer, P. S., Xie, M., Quilliam, M. A., Pleasance, S., Howlett, S. E., Yeung, P. K. F. (1992) Synthesis, characterization and calcium antagonistic activity of diltiazem metabolites. J. Med. Chem. 35: 3246-3253
11. McLean, A. M., Cefali, E. A., Roden, J. S., Gonzalez, M. A., Bialer, M. (1991) Stability of diltiazem in different biological fluids. Biopharm. Drug Dispos. 12: 327-334
12. Medical Letter (1993) Drugs for hypertension. Med. Lett. 35: 55-60
13. Medical Letter (1994) Drugs for stable angina pectoris. Med. Lett. 36: 111-114
14. Sugawara, Y., Ohashi, M., Nakamura, S., Usuki, S., Suzuki, T., Ito, Y., Kume, T., Harigaya, S., Nakao, A., Gaino, M., Inoue, H. (1988) Metabolism of diltiazem. I. Structures of new acidic and basic metabolites in rats, dog and man. J. Pharmacobiodyn. 11: 211-223
15. Sugihara, J., Sugawara, Y., Ando, H., Harigaya, S., Etoh, A., Kohno, K. (1984) Studies on the metabolism of diltiazem in man. J. Pharm. Dyn. 7: 24-32
16. Takeo, S., Tanonaka, K., Tazuma, Y., Fukao, N., Yoshikawa, C., Fukumoto, T., Tanaka, T. (1988) Diltiazem and verapamil reduce the loss of adenine nucleotide metabolites from hypoxic hearts. J. Mol. Cell. Cardiol. 20: 443-456
17. Tsui, B., Feng, J., Yeung, P. (1998) Pharmacokinetics and haemodynamic effects of diltiazem in rats: effect of route of administration. J. Pharm. Pharmacol. 50: 183-188
18. Weir, M. (1995) Diltiazem: ten years of clinical experience in the treatment of hypertension. J. Clin. Pharmacol. 35: 220-232
19. White, M. (1997) Role of neurohumoral modulation in congestive heart failure: focus on the new generation calcium channel blockers. Can. J. Hosp. Pharm. 50: 121-125
20. Yabana, H., Nagao, T., Sato, M. (1985) Cardiovascular effects of the metabolites of diltiazem in dogs. J. Cardiovasc. Pharmacol. 7: 152-157
21. Yeung, P. K. F., Montague, T. J., Tsui, B., McGregor, C. (1989) High performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: application to a pharmacokinetic study in healthy volunteers. J. Pharm. Sci. 78: 592-597
22. Yeung, P. K. F., Mosher, S. J., Quilliam, M. A., Montague, T. J. (1990) Species comparison of pharmacokinetics and metabolism of diltiazem in humans, dogs, rabbits, and rats. Drug Metab. Dispos. 18: 1055-1059
23. Yeung, P. K. F., Mosher, S. J., Klassen, G. A., McGilveray, I. J. (1991a) Stability of diltiazem and its metabolites in plasma during storage. Ther. Drug Monit. 13: 369-374
24. Yeung, P. K. F., Mosher, S. J., MacRae, D. A., Klassen, G. A. (1991b) Effect of diltiazem and its metabolites on the uptake of adenosine in blood: an in-vitro investigation. J. Pharm. Pharmacol. 43: 685-689
25. Yeung, P. K. F., Mosher, S. J., Pollak, P. T. (1991c) Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration. Eur. J. Drug Metab. Pharmacokinet. 16: 69-74
26. Yeung, P., Buckley, S., Hung, O., Pollak, P., Barclay, K., Feng, J., Farmer, P., Klassen, G. (1996) Steady-state plasma concentrations of diltiazem and its metabolites in patients and healthy volunteers. Ther. Drug Monit. 18: 40-45
27. Yeung, P., Buckley, S., Hung, O., Pollak, P., Barclay, K., Feng, J., Klassen, G. (1997) Effect of diltiazem on plasma concentrations of oxypurines and uric acid. Ther. Drug Monit. 19: 286-291